ICD-10-CM Billable Code

T80.52

Anaphylactic reaction due to vaccination

Clinical Classification Guidelines

Medical Intelligence & Overview

Anaphylactic reaction due to vaccination, classified under ICD-10 code T80.52, is a severe allergic response that can occur after receiving a vaccine. While vaccines are essential for preventing infectious diseases and are generally safe, in rare cases, individuals may experience an immediate and potentially life-threatening allergic reaction. Recognizing the symptoms and understanding the causes can help ensure prompt medical attention and treatment.

Causes & Symptoms

Clinical Causes: An allergic response to vaccine components such as egg protein, gelatin, latex, or antibiotics Previous history of allergic reactions to vaccines or their ingredients Genetic predisposition toward allergies Recent illness or immune system suppression at the time of vaccination Multiple vaccines administered simultaneously

Key Symptoms: Difficulty breathing or shortness of breath Swelling of the face, lips, tongue, or throat Hives or widespread skin rash Rapid or weak pulse Dizziness or fainting Nausea, vomiting, or abdominal pain Feeling of impending doom or severe anxiety

Diagnostic & Treatment

Diagnosis Path: Diagnosis of anaphylactic reaction involves prompt clinical assessment based on the sudden onset of symptoms following vaccination. Healthcare providers typically evaluate the patient's medical history, allergy history, and present symptoms. In some cases, skin tests or blood tests may be conducted later to identify specific allergies. The main diagnostic criterion is the rapid development of symptoms affecting multiple organ systems shortly after vaccination.

Treatment Protocols: Immediate treatment of anaphylactic reactions is critical and usually involves the administration of epinephrine, which can reverse airway swelling and improve blood pressure. Supportive measures include oxygen therapy, intravenous fluids, antihistamines, and corticosteroids to reduce inflammation and prevent recurrence. After stabilization, patients are monitored closely, and further allergy testing may be recommended to identify specific triggers. Hospitalization may be required in severe cases to ensure recovery and prevent complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T80.52 a billable ICD-10 code?
Yes, T80.52 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T80.52?
Clinical documentation must specify the nature of Anaphylactic reaction due to vaccination and any associated comorbidities for accurate reporting.

Cite this Clinical Reference